brl 42810 has been researched along with Skin Diseases in 4 studies
Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this randomized, double-blind, multicenter, acyclovir-controlled study, the efficacy and safety of famciclovir were evaluated for the treatment of herpes zoster in patients who were immunocompromised following bone marrow or solid organ transplantation or oncology treatment." | 9.09 | A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients. ( Belanger, R; Bezwoda, W; Boon, R; Ljungman, P; Saltzman, RL; Tyring, S, 2001) |
| "In this randomized, double-blind, multicenter, acyclovir-controlled study, the efficacy and safety of famciclovir were evaluated for the treatment of herpes zoster in patients who were immunocompromised following bone marrow or solid organ transplantation or oncology treatment." | 5.09 | A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients. ( Belanger, R; Bezwoda, W; Boon, R; Ljungman, P; Saltzman, RL; Tyring, S, 2001) |
| "Reactivation of varicella zoster virus (VZV) is a common event in patients undergoing allogeneic bone marrow transplantation (BMT) and may lead to life-threatening complications." | 2.69 | Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. ( Akhtar, M; DesJardin, J; Griffith, J; Koc, Y; Miller, KB; Schenkein, DP; Snydman, DR, 2000) |
| "We examined the incidence of herpes varicella-zoster virus (VZV) infection in 151 patients undergoing allogeneic BMT between August 1990 and September 1997 and who survived at least 3 months." | 2.69 | Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir. ( Beresford, JA; Grigg, A; Matthews, JP; Sasadeusz, J; Steer, CB; Szer, J, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dover, JS | 1 |
| Arndt, KA | 1 |
| Koc, Y | 1 |
| Miller, KB | 1 |
| Schenkein, DP | 1 |
| Griffith, J | 1 |
| Akhtar, M | 1 |
| DesJardin, J | 1 |
| Snydman, DR | 1 |
| Steer, CB | 1 |
| Szer, J | 1 |
| Sasadeusz, J | 1 |
| Matthews, JP | 1 |
| Beresford, JA | 1 |
| Grigg, A | 1 |
| Tyring, S | 1 |
| Belanger, R | 1 |
| Bezwoda, W | 1 |
| Ljungman, P | 1 |
| Boon, R | 1 |
| Saltzman, RL | 1 |
3 trials available for brl 42810 and Skin Diseases
| Article | Year |
|---|---|
Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome.
Topics: 2-Aminopurine; Acyclovir; Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Chickenp | 2000 |
Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir.
Topics: 2-Aminopurine; Acyclovir; Adolescent; Adult; Age of Onset; Aged; Analysis of Variance; Antiviral Age | 2000 |
A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients.
Topics: 2-Aminopurine; Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; Double-Blind Method; Famciclovi | 2001 |
1 other study available for brl 42810 and Skin Diseases
| Article | Year |
|---|---|
Dermatology.
Topics: 2-Aminopurine; Acyclovir; Antifungal Agents; Antiviral Agents; Dermatologic Agents; Dermatology; Der | 1997 |